Trial Profile
Phase Ib study of S 288310/S 488310 in patients with malignant mesothelioma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Asudemotide (Primary)
- Indications Mesothelioma
- Focus Adverse reactions
- 28 Mar 2016 New trial record